+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • May 2025
  • 179 Pages
  • Global
From
Vitiligo Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Vitiligo Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 192 Pages
  • Global
From
From
Scleroderma Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Scleroderma Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Loading Indicator